Robuta

https://www.clinicaltrialsarena.com/news/fosun-pharma-covid-vaccine-trial/ China's NMPA accepts Fosun Pharma's Covid-19 vaccine trial submission Jul 12, 2022 - China's NMPA has accepted an application submitted by Fosun Pharma seeking approval to trial Covid-19 vaccine candidate, BNT162b1. fosun pharmavaccine trialchinanmpaaccepts Sponsored https://www.verifiedprofiles.com/enter.php?prg=1&id=robuta&t=best&ad_id=verifiedprofiles_300x250_pg.gif Verified Profiles - World's Best Personals Tired of fake profiles? Us too. We verify every member before they can chat. https://digitalmedianet.com/fosun-pharma-deeply-embraces-ai-self-developed-pharmaid-decision-intelligence-platform-boosts-efficient-innovation/ Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts... fosun pharmadecision intelligencedeeplyembracesself https://www.worldpharmatoday.com/news/biontech-and-fosun-pharma-provide-covid-19-vaccine-doses-for-vaccination-of-german-expatriates-in-china/ BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in C Dec 27, 2022 - BioNTech SE and Shanghai Fosun Pharmaceutical announced that the companies provided approximately 11,500 doses of mRNA-based fosun pharmagerman expatriatesin cbiontechprovide https://aijourn.com/fosun-pharmas-small-molecule-innovative-drug-xh-s004-achieves-overseas-licensing-for-a-potential-total-of-645-million/ Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential... Aug 12, 2025 - SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed fosun pharmasmall moleculeinnovativedrugachieves